Board of Directors
GTA Board of Directors and Committee Chairs
Board of Directors
Chair (2022)
Dr. Sheroy Minocherhomji
Dr. Sheroy Minocherhomji is currently a Senior Director within the Nonclinical Safety and Toxicology department at Eli Lilly and Company. He has >10 years of industry and academic experience in regulatory and discovery toxicology, impurity qualification of drugs, genomics, precision oncology, DNA repair, and safety assessment of multi-modality therapeutics, from discovery through to marketing and in oncology, cardiometabolic disorders and neuroscience therapeutic areas.
He was previously a Principal Scientist/Toxicologist and Head of the Genetic Toxicology Unit within the Translational Safety department at Amgen and an Assistant Professor at the University of Copenhagen, Denmark. He received his M.Sc. and DIC degrees in Human Molecular Genetics from Imperial College London, UK and his PhD as a Marie Curie Fellow from the University of Copenhagen, Denmark in Health & Medical Sciences.
He has been invited to speak at numerous global conferences and has authored more than 20 peer-reviewed publications including 10 as first/co-first and 4 as senior last author in high-impact journals including Nature, Nature Cell Biology, PNAS, Molecular Cell and & Regulatory Toxicology & Pharmacology.
He has been the recipient of numerous awards and grants and most recently the Early-Stage Investigator and Emerging Scientist Awards by the Genetic Toxicology Association (GTA) and the Environmental Mutagenesis & Genomics Society (EMGS). He is currently Chair of the GTA, a member of the GTA’s board of directors, a steering committee member of HESI’s Genetic Toxicology Technical Committee (HESI-GTTC) and a past co-chair of the HESI-GTTC ecNGS working group.
Chair ELECT (2022)
Penny Leavitt MS DABT
Penny Leavitt has been dedicated to Genetic Toxicology efforts since joining Bristol Myers Squibb (BMS) in 2011. Current responsibilities are heavily weighted in mutagenic impurities risk assessment with a cross-functional role in Chemical Process Development and CMC Regulatory. Efforts support IND and NDA dossier submissions as well as responding to Health Authority requests as they arise. External efforts include data sharing projects with commercial in silico providers for genotoxic endpoints and contributing expert knowledge in external working groups. In addition, Penny is responsible for ensuring effective external partnerships with CROs and monitoring of Genetox studies. Prior to tenure at BMS, Penny’s career experience spanned multiple areas of drug discovery utilizing a breadth of techniques in both industry and academia, with a particular aptitude for microbiology, biochemistry, and chemistry SAR. Most recently, Penny has expanded horizons in general and regulatory Toxicology, with culmination of earning status as a Diplomate of American Board of Toxicology, achieving position of Nonclinical Safety Project Representative, and responsibilities in review/authoring internal exposure monographs deriving chemical exposure limits to support chemical development and related quality events. Penny has been a member of GTA since 2011. For the past few years she has volunteered to support efforts for the GTA annual meeting, in particular co-chairing the GTA student outreach, aligning with her demonstrated advocacy for mentoring young scientists throughout her 20+ career. Prior to tenure at BMS, Penny’s career experience spanned multiple areas of drug discovery utilizing a breadth of techniques in both industry and academia, with a particular aptitude for microbiology, biochemistry, and chemistry SAR. Most recently, Penny has expanded horizons in general and regulatory Toxicology, with culmination of earning status as a Diplomate of American Board of Toxicology, achieving position of Nonclinical Safety Project Representative, and responsibilities in review/authoring internal exposure monographs deriving chemical exposure limits to support chemical development and related quality events. Penny has been a member of GTA since 2011. For the past few years she has volunteered to support efforts for the GTA annual meeting, in particular co-chairing the GTA student outreach, aligning with her demonstrated advocacy for mentoring young scientists throughout her 20+ career.
Ashley J. Allemang MS

Maria Engel

Melisa Masuda-Herrera MS

Zhiying Ji

Wen Sun
